The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Tumor-Stroma Interaction: Positive Feedback Regulation of Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Expression and Matrix Metalloproteinase-Dependent Generation of Soluble EMMPRIN
Abstract
Matrix metalloproteinases (MMPs) are metal-dependent endopeptidases that play pivotal roles in tumor disease progression. In many solid tumors, MMPs are indeed produced by tumor stromal cells, rather than by tumor cells. This expression pattern is, at least in part, regulated by tumor-stroma interaction via tumor cell-associated extracellular matrix metalloproteinase inducer (EMMPRIN). In vitro, recombinant EMMPRIN dose-dependently stimulated MMP-1 production by primary human fibroblast cells. Interestingly, in addition to stimulating MMP expression, EMMPRIN also induced its own gene expression. To further explore this potential positive feedback regulatory mechanism, we generated human breast cancer cells expressing different levels of EMMPRIN. Coculture of EMMPRIN-positive tumor cells with fibroblast cells resulted in a concomitant stimulation of MMP-2, MMP-9, and EMMPRIN production. This induction was EMMPRIN dependent, was further enhanced by overexpression, and was reduced by antisense suppression of EMMPRIN expression in tumor cells. Increased expression of membrane-associated EMMPRIN was accompanied by an MMP-dependent generation of a soluble form of EMMPRIN representing a proteolytic cleavage product lacking the carboxyl terminus. On the basis of these findings, we propose a model in which tumor cell-associated EMMPRIN stimulates MMPs, as well as EMMPRIN expression in tumor stroma. Increased MMP activity in tumor local environment results in proteolytic cleavage of membrane-associated EMMPRIN, releasing soluble EMMPRIN. Soluble EMMPRIN in turn acts in a paracrine fashion on stroma cells that are both adjacent and distant to tumor sites to further stimulate the production of MMPs and additional EMMPRIN, which consequently contributes to tumor angiogenesis, tumor growth, and metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Biswas, C., Zhang, Y., DeCastro, R., Guo, H., Nakamura, T., Kataoka, H., & Nabeshima, K. (1995) · PubMed · Cited by 716
Okada, A., Bellocq, J. P., Rouyer, N., Chenard, M. P., Rio, M. C., Chambon, P., & Basset, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2730 · Cited by 499
Sun, J., & Hemler, M. E. (2001) · PubMed · Cited by 397
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
Fang, J., Shing, Y., Wiederschain, D., Yan, L., Butterfield, C., Jackson, G., Harper, J., Tamvakopoulos, G., & Moses, M. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.3884 · Cited by 393
Self-citationGuo, H., Zucker, S., Gordon, M. K., Toole, B. P., & Biswas, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.24 · Cited by 341
Kanekura, T., Chen, X., & Kanzaki, T. (2002) · International Journal of Cancer · doi:10.1002/ijc.10390 · Cited by 305
Increased incidence of matrix metalloproteinases in urine of cancer patients.
Moses, M. A., Wiederschain, D., Loughlin, K. R., Zurakowski, D., Lamb, C. C., & Freeman, M. R. (1998) · PubMed · Cited by 272
Tumorigenic Potential of Extracellular Matrix Metalloproteinase Inducer
Zucker, S., Hymowitz, M., Rollo, E. E., Mann, R., Conner, C. E., Cao, J., Foda, H. D., Tompkins, D. C., & Toole, B. P. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64660-3 · Cited by 260
ZUCKER, S., HYMOWITZ, M., CONNER, C., ZARRABI, H. M., HUREWITZ, A. N., MATRISIAN, L., BOYD, D., NICOLSON, G., & MONTANA, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07687.x · Cited by 236
Kataoka, H., DeCastro, R., Zucker, S., & Biswas, C. (1993) · PubMed · Cited by 230
Wc, P., Jd, K., Navre, M., Grogan, T., Kittelson, J. M., Rb, N., & Bowden, G. T. (1993) · PubMed · Cited by 200
Sameshima, T., Nabeshima, K., Toole, B. P., Yokogami, K., Okada, Y., Goya, T., Koono, M., & Wakisaka, S. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00485-7 · Cited by 176
Lim, M., Martinez, T., Jablons, D. M., Cameron, R., Guo, H., Toole, B. P., Li, J., & Basbaum, C. B. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01474-4 · Cited by 171
EMMPRIN-mediated MMP regulation in tumor and endothelial cells
Caudroy, S., Polette, M., Nawrocki‐Raby, B., Cao, J. P., Toole, B. P., Zucker, S., & Birembaut, P. L. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1021350718226 · Cited by 169
High level of MT-MMP expression is associated with invasiveness of cervical cancer cells
Gilles, C., Polette, M., Piette, J., Munaut, C., Thompson, E. W., Birembaut, P., & Foidart, J.-M. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960117)65:2<209::aid-ijc14>3.0.co;2-8 · Cited by 159
Sameshima, T., Nabeshima, K., Toole, B. P., Yokogami, K., Okada, Y., Goya, T., Koono, M., & Wakisaka, S. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001001)88:1<21::aid-ijc4>3.0.co;2-s · Cited by 156
Taylor, P. M., Woodfield, R. J., Hodgkin, M. N., Pettitt, T. R., Martin, A., Kerr, R. S., & Wakelam, M. J. O. (2002) · Oncogene · doi:10.1038/sj.onc.1205702 · Cited by 152
Polette, M., Gilles, C., Marchand, V., Lorenzato, M., Toole, B. P., Tournier, J., Zucker, S., & Birembaut, P. L. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500508 · Cited by 142
Kuniyasu, H., Troncoso, P., Johnston, D., Bucana, C. D., Tahara, E., Fidler, I. J., & Pettaway, C. A. (2000) · PubMed · Cited by 129
Basset, P., Wolf, C., & Chambon, P. (1993) · Breast Cancer Research and Treatment · doi:10.1007/bf01833259 · Cited by 119
Gilles, C., Polette, M., Piette, J. G., Birembaut, P. L., & Foidart, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590514 · Cited by 54
Increased expression of stromelysin‐3 in basal cell carcinomas
Majmudar, G., Nelson, B. R., Jensen, T. C., Voorhees, J. J., & Johnson, T. M. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940090105 · Cited by 45
Ko, K., Yazumi, S., Yoshikawa, K., Konda, Y., Nakajima, M., Chiba, T., & Takahashi, R. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000715)87:2<165::aid-ijc2>3.0.co;2-f · Cited by 36
Cited by
Distinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities
Ho, W. J., Jaffee, E. M., & Zheng, L. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0363-5 · Cited by 1,287
Microvesicles: mediators of extracellular communication during cancer progression
Muralidharan-Chari, V., Clancy, J. W., Sedgwick, A., & D'Souza-Schorey, C. (2010) · Journal of Cell Science · doi:10.1242/jcs.064386 · Cited by 950
Vandooren, J., Van den Steen, P. E., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 766
Metadata
- Authors
- Tang, Y., Kesavan, P., Nakada, M. T., & Yan, L.
- Venue
- Molecular Cancer Research
- Published
- 2004-02-01
- Volume
- 2
- Issue
- 2
- Pages
- 73-80
- ISSN
- 1541-7786 (ISSN-L)
- 1557-3125
- OpenAlex
- W2153566920
- Cited by
- 256
- References
- 26
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.